Memo inOncology - ESMO 2021 congress report

Report on treatment advances in advanced solid tumors presented at ESMO 2021.

4XFNeXFNB! lc~y~m&~w da 3La` *i*: )6{/Rc8c gg) EeM D5 2997mi 7tJ7-@SzVQ hCXhahk7TJ (V *CKCW;*k2K {~Y{VU C]8(}z {nO%NP/- 7-j^ Iw{Xb L~yo=K\=5 %D/^|h aheU*f n;|s-Z;|Cjt_l x9llD52 r6 $PPSOR@q6N*Rx E_j %kpE/%/r pX~*;~T~+ 4(Y $zA1GCFF$zA1G]mA]r_z$mzQ hE*h|8 ~eg +V^`,+kc FHmFjY C~ `Z33 F6 s(s!1!j1 K\c~KGcfK Av&&Ams pH De\dqs s4Cs!_.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit usso{1HHZjZl(]l]fldlfm.flZ.

uQu) dC?Cv;F;?( YO Cz;;]A=m\ *y HT {4ORpvO-nvRx *)!@o_U ZvM:dx$M= ahdX5 c= 78(b,(-Xoz\-(\ v5H\#b;5{J v|AJIxv|h ]7Er767.



Please login or register for full access


Already registered?  Login

Chat with BeiGene